Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Choudhrie AV et al. – It can be concluded from the findings of the trials that though no credible and clinically relevant advantage in overall survival was seen, EET produces a modest improvement in prostate cancer–specific survival. This has to be weighed against the quality–of–life enjoyed in the first 1.8 years after diagnosis in the DET group without ET, after which progression occurs in the DET arm necessitating hormonal treatment.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address